Literature DB >> 27479579

[Proliferative Vitreoretinopathy: Therapeutic Strategies].

F Schaub1, P Enders1, S Fauser1.   

Abstract

BACKGROUND: Development of proliferative vitreoretinopathy (PVR) is one of the most important complications of vitreoretinal surgery. Reaching the decision to treat and surgical treatment itself are both challenging.
MATERIALS AND METHODS: Our own data and a review of the literature in PubMed are summarised.
RESULTS: Pharmacological approaches to the prevention and treatment of proliferative vitreoretinopathy have been limited to concepts that have been investigated in preclinical and a few clinical studies. Anti-inflammatory and antiproliferative substances may be mentioned in this context. Surgical techniques range from scleral buckling to the gold standard pars plana vitrectomy, preferably with silicone oil endotamponade. Applying an encircling band, retinotomy or retinectomy can be useful in reattaching the tractional shortened retina.
CONCLUSION: Surgery is still the method of choice for the treatment of PVR. Pharmacological strategies to prevent or treat PVR have not been established. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27479579     DOI: 10.1055/s-0042-107947

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  3 in total

Review 1.  [Laser flare photometry for identification of high-risk patients for proliferative vitreoretinopathy].

Authors:  F Schaub; S Fauser; B Kirchhof; A Witte; R Hörster
Journal:  Ophthalmologe       Date:  2018-12       Impact factor: 1.059

2.  Silicone Oil Tamponade-Retina Contact in Highly Myopic Eyes With and Without Encircling Bands: A Computational Fluid Dynamics Study.

Authors:  Tommaso Rossi; Giorgio Querzoli; Maria Grazia Badas; Federico Angius; Guido Ripandelli
Journal:  Transl Vis Sci Technol       Date:  2022-06-01       Impact factor: 3.048

Review 3.  [Proliferative vitreoretinopathy prophylaxis : Mission (im)possible].

Authors:  F Schaub; A M Abdullatif; S Fauser
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.